Vladimir Vexler - Jan 10, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Stock symbol
CHRS
Transactions as of
Jan 10, 2022
Transactions value $
-$110,797
Form type
4
Date filed
1/12/2022, 03:39 PM
Previous filing
Jan 6, 2022
Next filing
Apr 5, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$59.3K -4.15K -3.6% $14.30 111K Jan 10, 2022 Direct F1, F2
transaction CHRS Common Stock Tax liability -$51.5K -3.58K -3.23% $14.36 107K Jan 11, 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units ("RSUs") that vested on January 10, 2022.
F2 Includes 101,666 RSUs.
F3 Represents the number of shares of common stock withheld to pay the related tax liability on RSUs that vested on January 11, 2022.
F4 Includes 91,249 RSUs.